Table 5.
Age-adjusted Incidence rate ratios for cytophilic IgG with malaria incidence from low to the end of high transmission season
| Antibodies/antigen | Parasitemia > 0 | Parasitemia > 2500 | Parasitemia > 5000 | ||||
|---|---|---|---|---|---|---|---|
| Age adjusted (95% CI) | p | Age adjusted (95% CI) | p | Age adjusted (95% CI) | p* | ||
| IgG1 | MSP3 | 0.94 (0.897, 0.989) | 0.016 | 0.93 (0.872, 0.988) | 0.02 | 0.93 (0.874, 0.995) | 0.034 |
| MSP2a | 0.99 (0.956, 1.031) | 0.7 | 0.98 (0.936, 1.029) | 0.44 | 0.97 (0.919, 1.014) | 0.16 | |
| MSP2b | 1.00 (0.959, 1.037) | 0.90 | 0.98 (0.936, 1.033) | 0.5 | 0.98 (0.932, 1.032) | 0.45 | |
| GLURP-R0 | 0.93 (0.892, 0.965) | 0.0002 | 0.90 (0.851, 0.942) | 0.00002 | 0.89 (0.845, 0.939) | 0.00002 | |
| GLURP-R2 | 0.96 (0.932, 0.982) | 0.001 | 0.94 (0.914, 0.976) | 0.0007 | 0.94 (0.912, 0.977) | 0.001 | |
| IgG3 | MSP3 | 0.97 (0.940, 0.996) | 0.024 | 0.95 (0.913, 0.983) | 0.004 | 0.94 (0.908, 0.981) | 0.003 |
| MSP2a | 0.99 (0.960, 1.020) | 0.49 | 0.97 (0.934, 1.008) | 0.12 | 0.97 (0.929, 1.005) | 0.091 | |
| MSP2b | 0.98 (0.948, 1.005) | 0.1 | 0.95 (0.911, 0.981) | 0.003 | 0.94 (0.903, 0.975) | 0.0011 | |
| GLURP-R0 | 0.98 (0.942, 1.010) | 0.16 | 0.96 (0.918, 1.003) | 0.068 | 0.96 (0.913, 1.001) | 0.056 | |
| GLURP-R2 | 0.96 (0.936, 0.982) | 0.0007 | 0.94 (0.907, 0.966) | 0.00003 | 0.93 (0.903, 0.964) | 0.00003 | |
* p ≤ 0.05 was considered as statistically significant